ESR1 and breast cancer: For example, a study on estrogen receptor alpha-positive dormant breast cancer treatment found that AMPK activated by metformin or high fatty acid intake may induce persistency of breast cancer cells under endocrine therapy; however, fatty acid oxidation inhibitors in combination with endocrine therapy may eliminate dormant cancer cells [138].